Two-dimensional gel electrophoresis using immobilized pH gradient strips and Flamingo™ fluorescent gel stain identified non-nuclear proteins possibly related to malignant tumour progression

Anticancer Research

Volumn 31, Issue 4, 2011, Pages 1259-1263

  Kuramitsu, Yasuhiro ^a   Hayashi, Eiko ^a   Okada, Futoshi ^b   Zhang, Xiulian ^a   Ueyama, Yoshiya ^a   Nakamura, Kazuyuki ^a  

^a YAMAGUCHI UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b TOTTORI UNIVERSITY   (Japan)

Author keywords

Fibrosarcoma; Inflammation associated carcinogenesis; Non nuclear protein; Progression

Indexed keywords

60 S ACIDIC RIBOSOMAL PROTEIN P2; ADENYLATE KINASE; ALPHA ENOLASE; CALMODULIN; CYSTATIN; CYTOSKELETON ASSOCIATED PROTEIN 4; GLUTATHIONE TRANSFERASE M1; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; HEAT SHOCK PROTEIN 10; HEAT SHOCK PROTEIN 60; HEAT SHOCK PROTEIN 70; HEAT SHOCK PROTEIN 90; HYPOXIA UP REGULATED PROTEIN 1; LIPOCORTIN 1; LIPOCORTIN 5; MEMBRANE PROTEIN; NON NUCLEAR PROTEIN; PROLINE; PROTEASOME; PYRROLINE 5 CARBOXYLATE REDUCTASE; PYRUVATE KINASE; RETICULOCALBIN 1; RIBOSOME PROTEIN; T COMPLEX PROTEIN 1 SUBUNIT ALPHA B; THIOREDOXIN; TRIOSEPHOSPHATE ISOMERASE; UNCLASSIFIED DRUG; VALOSIN CONTAINING PROTEIN; VIMENTIN; VOLTAGE DEPENDENT ANION CHANNEL 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARCINOGENESIS; CONTROLLED STUDY; DOWN REGULATION; FLUORESCENCE; HYPOXIA; MASS SPECTROMETRY; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEOMICS; TWO DIMENSIONAL ELECTROPHORESIS; UPREGULATION;

ANIMALS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CYTOPLASM; DISEASE PROGRESSION; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; FIBROSARCOMA; ISOELECTRIC FOCUSING; MICE; MICE, INBRED C57BL; PROTEOME; PROTEOMICS; PROTON-MOTIVE FORCE; STAINING AND LABELING; TANDEM MASS SPECTROMETRY; TUMOR CELLS, CULTURED;

EID: 79956121834     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Okada F, Hosokawa M, Hamada JI, Hasegawa J, Kato M, Mizutani M, Ren J, Takeichi N and Kobayashi H: Malignant progression of a mouse fibrosarcoma by host cells reactive to a foreign body (gelatin sponge). Br J Cancer 66: 635-639, 1992.
2. Kuramistu Y and Nakamura K: Proteomic analysis in cancer patients. Humana Press (USA); Cancer Drug Discovery and Development™ Genomics and Pharmacogenomics in Anticancer Drug Development and Clinical Response Innocenti F (ed.). pp. 33-45, 2008.
3. Kuramitsu Y, Hayashi E, Okada F, Tanaka T, Zhang X, Ueyama Y and Nakamura K: Proteomic analysis for nuclear proteins related to tumour malignant progression: a comparative proteomic study between malignant progressive cells and regressive cells. Anticancer Res 30: 2093-2099, 2010.
4. Hayashi E, Kuramitsu Y, Okada F, Fujimoto M, Zhang X, Kobayashi M, Iizuka N, Ueyama Y and Nakamura K: Proteomic profiling for cancer progression: Differential display analysis for the expression of intracellular proteins between regressive and progressive cancer cell lines. Proteomics 5: 1024-1032, 2005. (Pubitemid 40469032)
5. Ishikawa M, Hosokawa M, Oh-hara N, Niho Y and Kobayashi H: Marked granulocytosis in C57BL/6 mice bearing a transplanted BMT-11 fibrosarcoma. J Natl Cancer Inst 78: 567-571, 1987.
6. Kuramitsu Y, Hayashi E, Okada F, Tanaka T, Zhang X, Ueyama Y and Nakamura K: Proteomic analysis for nuclear proteins related to tumour malignant progression: a comparative proteomic study between malignant progressive cells and regressive cells. Anticancer Res 30: 2093-2099, 2010.
7. Kuramitsu Y, Miyamoto H, Tanaka T, Zhang X, Fujimoto M, Ueda K, Tanaka T, Hamano K and Nakamura K: Proteomic differential display analysis identified up-regulated astrocytic phsphoprotein PEA-15 in human malignant pleural mesothelioma cell lines. Proteomics 9: 5078-5089, 2009.
8. Tanaka T, Kuramitsu Y, Fujimoto M, Naito S, Oka M and Nakamura K: Down-regulation of two isoforms of ubiquitin carboxyl-terminal hydrolase isozyme L1 (UCH-L1) correlates with high metastatic potentials of human SN12C renal cell carcinoma cell clones. Electrophoresis 29: 2651-2659, 2008. (Pubitemid 351911893)
9. Kuramitsu Y, Baron B, Yoshino S, Zhang X, Tanaka T, Yashiro M, Hirakawa K, Oka M and Nakamura K: Proteomic differential display analysis shows up-regulation of 14-3-3 protein sigma in human scirrhous-type gastric carcinoma cells. Anticancer Res 30: 4459-4465, 2010.
10. Kuramitsu Y, Taba K, Ryozawa S, Yoshida K, Tanaka T, Zhang X, Maehara S, Maehara Y, Sakaida I and Nakamura K: Identification of up- and down-regulated proteins in gemcitabine-resistant pancreatic cancer cells using two-dimensional gel electrophoresis and mass spectrometry. Anticancer Res 30: 3367-3372, 2010.
11. Kuramitsu Y, Hayashi E, Okada F, Zhang X, Tanaka T, Ueyama Y and Nakamura K: Staining with highly sensitive Coomassie brilliant blue SeePico™ stain after Flamingo™ fluorescent gel stain is useful for cancer proteomic analysis by means of two-dimensional gel electrophoresis. Anticancer Res 30: 4001-4005, 2010.
12. Yuan X, Kuramitsu Y, Furamoto H, Zhang X, Hayashi E, Fujimoto M and Nakamura K: Nuclear protein profiling of Jurkat cells during heat stress-induced apoptosis by two-dimensional gel electrophoresis and tandem mass spectrometry. Electrophoresis 28: 2018-2026, 2007. (Pubitemid 47040407)
13. Takashima M, Kuramitsu Y, Yokoyama Y, Iizuka N, Fujimoto M, Sakaida I, Okita K, Oka M and Nakamura K: Proteomic analysis of autoantibodies in patients with hepatocellular carcinoma. Proteomics 6: 3894-3900, 2006. (Pubitemid 44065166)
14. Takashima M, Kuramitsu Y, Yokoyama Y, Iizuka N, Fujimoto M, NIshisaka T, Sakaida I, Okita K, Oka M and Nakamura, K: Overexpression of alpha enolase in hepatitis C virus-related hepatocellular carcinoma: association with tumor progression as determined by proteomic analysis. Proteomics 5: 1686-1692, 2005. (Pubitemid 40593274)
15. Namba T, Hoshino T, Tanaka K, Tsutsumi S, Ishihara T, Mima S, Suzuki K, Ogawa S and Mizushima T: Up-regulation of 150-kDa oxygen-regulated protein by celecoxib in human gastric carcinoma cells. Mol Pharmacol 77: 860-870, 2007. (Pubitemid 46294098)
16. Stojadinovic A, Hooke JA, Shriver CD, Nissan A, Kovatich AJ, Kao TC, Ponniah S, Peoples GE and Moroni M: HYOU1/Orp150 expression in breast cancer. Med Sci Monit 13: 231-239, 2007.
17. Fathallah DM, Cherif D, Dellagi K and Arnaout MA: Molecular cloning of a novel human HSP70 from a B-cell line and its assignment to chromosome 5. J Immunol 151: 810-813, 1993. (Pubitemid 23215746)
18. Garg M, Kanojia D, Seth A, Kumar R, Gupta A, Surolia A and Suri A: Heat-shock protein 70-2 (HSP70-2) expression in bladder urothelial carcinoma is associated with tumour progression and promotes migration and invasion. Eur J Cancer 46: 207-215, 2010.
19. Ramp U, Mahotka C, Heikaus S, Shibata T, Grimm MO, Willers R and Gabbert HE: Expression of heat-shock protein 70 in renal cell carcinoma and its relation to tumor progression and prognosis. Histol Histopathol 22: 1099-1107, 2007. (Pubitemid 47470304)
20. McCarthy MM, Pick E, Kluger Y, Gould-Rothberg B, Lazova R, Camp RL, Rimm DL and Kluger HM: HSP90 as a marker of progression in melanoma. Ann Oncol 19: 590-594, 2008.
21. Moser C, Lang SA and Stoeltzing O: Heat-shock protein 90 (HSP90) as a molecular target for therapy of gastrointestinal cancer. Anticancer Res 29: 2031-2042, 2009.
22. Vuoriluoto K, Haugen H, Kiviluoto S, Mpindi JP, Nevo J, Gjerdrum C, Tiron C, Lorens JB and Ivaska J: Vimentin regulates EMT induction by Slug and oncogenic H-Ras and migration by governing Axl expression in breast cancer. Oncogene 2010 Nov 8. [Epub ahead of print]
23. Zhu QS, Rosenblatt K, Huang KL, Lahat G, Brobey R, Bolshakov S, Nguyen T, Ding Z, Belousov R, Bill K, Luo X, Lazar A, Dicker A, Mills GB, Hung MC and Lev D: Vimentin is a novel AKT1 target mediating motility and invasion. Oncogene 30: 457-470, 2011.
24. Liu Z, Brattain MG and Appert H: Differential display of reticulocalbin in the highly invasive cell line, MDA-MB-435, versus the poorly invasive cell line, MCF-7. Biochem Biophys Res Commun 231: 283-289, 1997. (Pubitemid 27214298)
25. de Graauw M, van Miltenburg MH, Schmidt MK, Pont C, Lalai R, Kartopawiro J, Pardali E, Le Dévédec SE, Smit VT, van der Wal A, Van't Veer LJ, Cleton-Jansen AM, ten Dijke P and van de Water B: Annexin Al regulates TGF-beta signaling and promotes metastasis formation of basal-like breast cancer cells. Proc Natl Acad Sci USA 107: 6340-6345, 2010.